Effect of continuous nursing on treatment compliance and side effect management of coronary heart disease

Table 1 Comparison of patients' general data

Group	Experimental group	Control group	F/t	P value
Age (yr)	64.90 ± 5.31	65.73 ± 3.15	-0.736	0.46
Gender (Male/female)	13/17	14/ 16	0.59	0.44
Body mass index	24.37 ± 1.81	23.96 ± 2.13	0.80	0.42
Smoking history (pack/yr)	16/14	15/ 14	0.64	0.42
High blood pressure (Yes/No)	14/16	13/17	0.58	0.44
Diabetes (Yes/No)	8/22	7/23	0.59	0.45
Glycosylated hemoglobin (%)	6.50 ± 0.68	5.51 ± 0.72	-0.07	0.94
Total cholesterol (mmoL/L)	5.48 ± 0.68	5.68 ± 0.72	-1.09	0.28
Triglyceride (mmoL/L)	1.65.48 ± 0.49	1.58 ± 0.42	-2.53	0.20
Low density lipoprotein (mmoL/L)	3.18 ± 0.55	3.50 ± 0.45	-1.60	0.11
Phospholipid protein A1 (g/L)	1.06 ± 0.21	0.98 ± 0.17	1.58	0.12
Phospholipid protein B (g/L)	1.57 ± 0.35	1.53 ± 0.36	0.43	0.67
Lipoprotein (mg/dL)	127.25 ± 7.93	134.42 ± 9.39	-1.92	0.06

Table 2 Comparison of anxiety and depression between the two groups before and after intervention

Group	n	SAS		SDS
		Before intervention	After intervention	Before intervention	After intervention
Experimental group	30.00	57.33 ± 3.01	41.33 ± 3.42	50.40 ± 1.45	39.47 ± 1.57
Control group	30.00	56.27 ± 2.89	44.9 ± 3.1	52.77 ± 1.43	41.37 ± 1.35
t		-2.37	-1.90	1.07	-3.57
P value		0.37	P < 0.01	0.17	P < 0.01

SAS: Self-rating anxiety scale; SDS: Self-rating depression scale.

Table 3 Comparison of compliance patterns between the two groups before and after intervention

Group	n	Face therapy		Avoidance therapy
		Before intervention	After intervention	Before intervention	After intervention
Experimental group	30.00	17.20 ± 1.75	13.13 ± 1.38	21.63 ± 1.54	13.70 ± 1.62
Control group	30.00	17.37 ± 0.96	15.67 ± 1.08	22.27 ± 1.29	15.13 ± 1.55
t		0.23	-3.54	-0.63	-1.43
P value		0.45	P < 0.01	0.09	P < 0.01

Table 4 Comparison of treatment compliance between the two groups after intervention

Group	n	Complete compliance	Partial compliance	Noncompliance
Experimental group	30	18	8	4
Control group	30	10	12	8
χ2 value	3.96
P value	0.047

Table 5 Comparison of pelvic floor function between the two groups before and after intervention

Group	n	Bladder function		Gastrointestinal function
		Before intervention	After intervention	Before intervention	After intervention
Experimental group	30	16.83 ± 1.72	10.47 ± 1.3	23.27 ± 3.37	13.60 ± 1.30
Control group	30	15.9 ± 1.16	10.2 ± 1.22	24.67 ± 2.92	14.77 ± 1.48
t		0.27	0.93	-1.40	-1.17
P value		0.42	0.02	0.09	P < 0.01